Galena Biopharma (GALE) Misses Q4 EPS by 7c
Tweet
Share
E-mail
Get Alerts GALE Hot Sheet
Join SI Premium – FREE
Galena Biopharma (NASDAQ: GALE) reported Q4 EPS of ($0.12), $0.07 worse than the analyst estimate of ($0.05).
For earnings history and earnings-related data on Galena Biopharma (GALE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Visa (V) stock rises as Q2 earnings, revenue come ahead of estimates
- Highwoods Properties (HIW) Tops Q1 EPS by 6c, provides guidance
- West Fraser Timber Co. Ltd. (WFG) Tops Q1 EPS by 17c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
